- Investing Ideas
- /
- Mexican Pharmaceuticals & Biotech Potentially Undervalued Companies
Mexican Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
73
Companies with a Value score of at least 3, ordered by Value score
73 companies
Biogen
Market Cap: Mex$19.9b
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally.
BIIB *
Mex$2,535.00
7D
-4.2%
1Y
-34.7%
Vertex Pharmaceuticals
Market Cap: Mex$97.9b
A biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF).
VRTX *
Mex$6,982.68
7D
-1.8%
1Y
-23.4%
ACADIA Pharmaceuticals
Market Cap: Mex$3.6b
A biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United States.
ACAD *
Mex$440.00
7D
n/a
1Y
n/a
BioMarin Pharmaceutical
Market Cap: Mex$10.1b
A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.
BMRN *
Mex$1,077.32
7D
0%
1Y
n/a
Bayer
Market Cap: Mex$26.8b
Operates as a life science company worldwide.
BAYN N
Mex$615.18
7D
0%
1Y
n/a
Ardelyx
Market Cap: Mex$1.4b
Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.
ARDX *
Mex$122.20
7D
0%
1Y
n/a
Haleon
Market Cap: Mex$29.2b
Engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific.
HLN1 N
Mex$183.32
7D
0%
1Y
n/a
Fortrea Holdings
Market Cap: Mex$1.8b
A contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide.
FTRE1 *
Mex$435.30
7D
0%
1Y
n/a
United Therapeutics
Market Cap: Mex$19.2b
A biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally.
UTHR *
Mex$5,672.39
7D
0%
1Y
n/a
GSK
Market Cap: Mex$59.2b
Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.
GSK N
Mex$750.00
7D
0%
1Y
-0.07%
BioCryst Pharmaceuticals
Market Cap: Mex$1.6b
A biotechnology company, develops oral small-molecule and injectable protein therapeutics to treat rare diseases.
BCRX *
Mex$159.50
7D
0%
1Y
n/a
Mirum Pharmaceuticals
Market Cap: Mex$3.7b
A biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases.
MIRM *
Mex$1,256.12
7D
0%
1Y
n/a
Sanofi
Market Cap: Mex$95.3b
Engages in the research, development, manufacture, and marketing of therapeutic solutions.
SNY N
Mex$836.00
7D
-3.1%
1Y
-24.6%
Agios Pharmaceuticals
Market Cap: Mex$2.0b
A biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United States.
AGIO *
Mex$1,222.00
7D
0%
1Y
n/a
WuXi Biologics (Cayman)
Market Cap: Mex$61.6b
An investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People’s Republic of China, North America, Europe, Singapore, Japan, South Korea, and Australia.
2269 N
Mex$62.53
7D
0%
1Y
n/a
PeptiDream
Market Cap: Mex$278.1b
A biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics.
4587 N
Mex$378.19
7D
0%
1Y
n/a
Genmab
Market Cap: Mex$114.0b
A biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark.
GMAB N
Mex$5,270.00
7D
15.3%
1Y
n/a
Bausch Health Companies
Market Cap: Mex$2.4b
Operates as a diversified specialty pharmaceutical and medical device company, develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, generic pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health in the United States and internationally.
BHC N
Mex$125.00
7D
0%
1Y
n/a
Ultragenyx Pharmaceutical
Market Cap: Mex$3.9b
A biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Latin America, Europe, the Middle East, Africa, and the Asia-Pacific.
RARE *
Mex$1,150.56
7D
0%
1Y
n/a
Merck KGaA
Market Cap: Mex$63.7b
Operates as a science and technology company in Germany.
MRK1 N
Mex$3,299.85
7D
0%
1Y
n/a
AstraZeneca
Market Cap: Mex$169.9b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZN1 N
Mex$2,806.92
7D
-0.5%
1Y
n/a
Qiagen
Market Cap: Mex$9.5b
Provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally.
QIA N
Mex$912.70
7D
0%
1Y
n/a
Zoetis
Market Cap: Mex$62.5b
Engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health products in the United States and internationally.
ZTS *
Mex$2,633.00
7D
-3.8%
1Y
-31.8%
argenx
Market Cap: Mex$36.9b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX N
Mex$14,210.00
7D
0%
1Y
34.5%
BioNTech
Market Cap: Mex$23.6b
A biotechnology company, develops and commercializes immunotherapies to treat cancer and infectious diseases in Germany.
BNTX N
Mex$1,780.00
7D
0.1%
1Y
-21.8%
Charles River Laboratories International
Market Cap: Mex$9.0b
Charles River Laboratories International, Inc.
CRL *
Mex$4,066.92
7D
0%
1Y
n/a
Gerresheimer
Market Cap: Mex$3.6b
Manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally.
GXI N
Mex$1,649.75
7D
0%
1Y
n/a
Gilead Sciences
Market Cap: Mex$137.7b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILD *
Mex$2,081.75
7D
1.4%
1Y
26.0%
Ipsen
Market Cap: Mex$9.2b
Operates as a biopharmaceutical company worldwide.
IPN N
Mex$2,448.52
7D
0%
1Y
n/a
Ono Pharmaceutical
Market Cap: Mex$1.3t
Engages in production, purchase, and sale of pharmaceuticals and diagnostic reagents worldwide.
4528 N
Mex$341.69
7D
0%
1Y
-34.5%
Amgen
Market Cap: Mex$146.0b
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.
AMGN *
Mex$5,144.39
7D
-0.8%
1Y
-18.7%
Revvity
Market Cap: Mex$9.6b
Provides health sciences solutions, technologies, and services.
RVTY *
Mex$1,662.25
7D
0%
1Y
n/a
Thermo Fisher Scientific
Market Cap: Mex$173.4b
Provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally.
TMO *
Mex$8,520.00
7D
-1.5%
1Y
-30.0%
Bristol-Myers Squibb
Market Cap: Mex$89.8b
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.
BMY *
Mex$807.30
7D
-4.0%
1Y
-20.9%
Daiichi Sankyo Company
Market Cap: Mex$6.8t
Manufactures and sells pharmaceutical products in Japan, North America, Europe, and internationally.
4568 N
Mex$493.73
7D
0%
1Y
n/a
Roche Holding
Market Cap: Mex$218.8b
Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.
ROG N
Mex$6,042.01
7D
0%
1Y
n/a